Tapahtumakalenteri

joulukuu 02

Cancer IO Sebinar Session IV: Adoptive Cell Therapies

This interactive bi-monthly sebinar series aims to bring you the newest developments in the field of immuno-oncology presented by leading scientists. Every sebinar will have an important interactive element in the form of a panel discussion, where the invited speaker discusses a timely topic with local scientists and clinicians. Sebinar attendants are welcomed to participate in the discussion using the Q&A feature.
 
This time we will hear about the latest developments in Adoptive Cell Therapies. This time we will hear about the latest developments in Adoptive Cell Therapies. We have the honor of hosting Boris Engels; Associate Director of the Novartis Institutes for Biomedical Research (Cambridge, USA), Dr. Sirpa Leppä (Physician in charge of the ward, Clinical Trial Unit of the Helsinki University Hospital and Professor at the University of Helsinki) and Dr. Anil Thorakura, Head of Immuno-Oncology at Orion Oy. In the panel discussion, we address opportunities and hurdles of taking adoptive cell therapies from bench to bedside.
 
Program:

15:00-15:10 Introduction. Dr. Anil Thotakura, Orion Pharmaceuticals

15:10-15:20 Clinical trials with CAR-T therapies. Prof. Sirpa Leppä, Helsinki University Hospital

15:20-16:10 Keynote (Title TBA). Dr. Boris Engels, Associate Director of the Novartis Institutes for Biomedical Research, Cambridge, USA

16:10-16:45 Panel: Opportunities and hurdles with clinical implementation of adoptive cell therapy.
Panelists: Boris Engels, Sirpa Leppä, Anil Thotakura, Matti Korhonen (Finnish Red Cross Blood Services)
 
Session Chair: Prof. Juha Klefström, Cancer IO

Aloitusaika: 02.12.2021 15:00
Lopetusaika: 02.12.2021 16:45
Kesto: 1 hour 45 minutes
Sijainti: remotely
Tyyppi: Webinar
Organisaatio: Cancer IO
Yhteyshenkilö: heidi.haikala@helsinki.fi
joulukuu 03

Dissertaion: Toni Jäntti

​Toni Jäntti, Faculty of Medicine, Doctoral Programme in Clinical Research
Biomarkers in the assessment of prognosis and organ injury in cardiogenic shock

Opponent: docent Heikki Miettinen, University of Eastern Finland


Aloitusaika: 03.12.2021 12:00
Lopetusaika: 03.12.2021 14:00
Kesto: 2 hours
Sijainti: HUS Puistosairaala, Niilo Hallman sali, Stenbäckinkatu 11
Tyyppi: Dissertation
Organisaatio: UH, Faculty of Medicine
Yhteyshenkilö: toni.jantti@hus.fi
joulukuu 03

Dissertation: Verna Louhivuori

​Verna Louhivuori, Faculty of Medicine, Doctoral Programme in Biomedicine
Receptor signaling mechanisms in neural progenitor cell differentiation and alterations in a mouse model for Fragile X Syndrome

Opponent: PhD Eleanor Coffey, University of Turku/Åbo Academi


 

Aloitusaika: 03.12.2021 13:00
Lopetusaika: 03.12.2021 15:00
Kesto: 2 hours
Sijainti: Haartman Institute, lecture hall 2, Haartmaninkatu 3, 00290 Helsinki
Tyyppi: Dissertation
Organisaatio: UH, Faculty of Medicine
Yhteyshenkilö: verna.louhivuori@helsinki.fi
joulukuu 03

Dissertation: Tuomas Mertsalmi

​Tuomas Mertsalmi, Faculty of Medicine, Doctoral Programme in Clinical Research
​The role of the microbiota-gut-brain axis in Parkinson’s disease

Opponent: professor Per Borghammer, Aarhus University



Aloitusaika: 03.12.2021 13:00
Lopetusaika: 03.12.2021 15:00
Kesto: 2 hours
Sijainti: Biomedicum1, lecture hall 3, Haartmaninkatu 8, 00290 Helsinki
Tyyppi: Dissertation
Organisaatio: UH, Faculty of Medicine
Yhteyshenkilö: tuomas.mertsalmi@helsinki.fi
joulukuu 03

Dissertation: Nicolas Martinez Majander

​Nicolas Martinez-Majander, Faculty of Medicine, Doctoral Programme in Clinical Research
 
Cryptogenic ischemic stroke in young adults : characteristics and less well-documented risk factors

Opponent: professor Heinrich Mattle, Department of Neurology, Inselspital, University of Bern, Switzerland


Aloitusaika: 03.12.2021 13:00
Lopetusaika: 03.12.2021 15:00
Kesto: 2 hours
Sijainti: Porthania PII, Yliopistonkatu 3, Helsinki
Tyyppi: Dissertation
Organisaatio: UH, Faculty of Medicine
Yhteyshenkilö: nicolas.martinez-majander@hus.fi